Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ganslmayer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|December 12, 1989
[Current status in the therapy of ischemic cerebrovascular disorders]F Regli, M Ganslmayer
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|September 16, 2015
[Toxic megacolon]M Leppkes, M Ganslmayer, R Strauß, et al.
Schweizerische Medizinische Wochenschrift|April 11, 1992
[Preliminary evaluation of the Profilomat, a new portable blood pressure recorder]M Ganslmayer, F Perret, B Waeber, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1990
Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patientsY Christen, M Ganslmayer, B Waeber, et al.
British Journal of Cancer|March 5, 2002
Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cellsC Herold, M Ocker, M Ganslmayer, et al.
International Journal of Oncology|December 18, 2001
Combined in vitro anti-tumoral action of tamoxifen and retinoic acid derivatives in hepatoma cellsC Herold, M Ganslmayer, M Ocker, et al.
International Journal of Oncology|July 31, 2003
Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cellsChristoph Herold, M Ganslmayer, M Ocker, et al.
Hepato-Gastroenterology|July 8, 2009
Liver function under interferon/ribavirin therapy of chronic hepatitis CS Stintzing, C Schmitt, M Ocker, et al.
Gut|August 16, 2005
Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancerM Ocker, D Neureiter, M Lueders, et al.
Clinical Pharmacology and Therapeutics|August 1, 1991
Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteersM Burnier, M Ganslmayer, F Perret, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|December 12, 1989
[Current status in the therapy of ischemic cerebrovascular disorders]F Regli, M Ganslmayer
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|September 16, 2015
[Toxic megacolon]M Leppkes, M Ganslmayer, R Strauß, et al.
Schweizerische Medizinische Wochenschrift|April 11, 1992
[Preliminary evaluation of the Profilomat, a new portable blood pressure recorder]M Ganslmayer, F Perret, B Waeber, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1990
Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patientsY Christen, M Ganslmayer, B Waeber, et al.
British Journal of Cancer|March 5, 2002
Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cellsC Herold, M Ocker, M Ganslmayer, et al.
International Journal of Oncology|December 18, 2001
Combined in vitro anti-tumoral action of tamoxifen and retinoic acid derivatives in hepatoma cellsC Herold, M Ganslmayer, M Ocker, et al.
International Journal of Oncology|July 31, 2003
Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cellsChristoph Herold, M Ganslmayer, M Ocker, et al.
Hepato-Gastroenterology|July 8, 2009
Liver function under interferon/ribavirin therapy of chronic hepatitis CS Stintzing, C Schmitt, M Ocker, et al.
Gut|August 16, 2005
Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancerM Ocker, D Neureiter, M Lueders, et al.
Clinical Pharmacology and Therapeutics|August 1, 1991
Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteersM Burnier, M Ganslmayer, F Perret, et al.
Pageof 1